A

AFT Pharmaceuticals Ltd
NZX:AFT

Watchlist Manager
AFT Pharmaceuticals Ltd
NZX:AFT
Watchlist
Price: 2.84 NZD 1.43% Market Closed
Market Cap: 297.8m NZD
Have any thoughts about
AFT Pharmaceuticals Ltd?
Write Note

Gross Margin
AFT Pharmaceuticals Ltd

44.6%
Current
46%
Average
48.4%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
44.6%
=
Gross Profit
88.5m
/
Revenue
198.5m

Gross Margin Across Competitors

Country NZ
Market Cap 297.8m NZD
Gross Margin
45%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 750.9B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 2.8T DKK
Gross Margin
85%
Country US
Market Cap 346.5B USD
Gross Margin
69%
Country US
Market Cap 250.3B USD
Gross Margin
77%
Country CH
Market Cap 199.5B CHF
Gross Margin
73%
Country UK
Market Cap 161.2B GBP
Gross Margin
82%
Country CH
Market Cap 171.3B CHF
Gross Margin
75%
Country US
Market Cap 149.9B USD
Gross Margin
71%
No Stocks Found

AFT Pharmaceuticals Ltd
Glance View

Market Cap
297.8m NZD
Industry
Pharmaceuticals

AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. The firm's segments include New Zealand, Australia, Asia and Rest of World. The firm's products include Crystaderm, Maxigesic, Coco-scalp, Maxiclear, RestoraNail and Myconail, among others. The firm's NasoSURF Nebuliser is in pilot scale production. The firm is focused on conducting clinical for Maxigesic oral dose forms. The firm is also conducting clinical trials of Maxigesic intravenous (IV). Maxigesic PE is a cold and flu variant. Its subsidiary, AFT Pharmaceuticals (AU) Pty Ltd, is engaged in distribution of pharmaceuticals in Australia. Its subsidiary, AFT Pharmaceuticals Singapore Pte Ltd, is engaged in the registration of pharmaceuticals in Singapore. Its subsidiary, AFT Pharmaceuticals (S.E. Asia) Sdn Bhd, is engaged in the distribution of pharmaceuticals in Malaysia.

AFT Intrinsic Value
4.72 NZD
Undervaluation 40%
Intrinsic Value
Price
A

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
44.6%
=
Gross Profit
88.5m
/
Revenue
198.5m
What is the Gross Margin of AFT Pharmaceuticals Ltd?

Based on AFT Pharmaceuticals Ltd's most recent financial statements, the company has Gross Margin of 44.6%.